Anti-eIF4EBP1 antibody [Y330]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal eIF4EBP1 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.
View Alternative Names
Eukaryotic translation initiation factor 4E-binding protein 1, 4E-BP1, eIF4E-binding protein 1, Phosphorylated heat- and acid-stable protein regulated by insulin 1, PHAS-I, EIF4EBP1
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-eIF4EBP1 antibody [Y330] (AB32130)
Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling eIF4EBP1 with purified ab32130 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Left).
Low expression in mitotic phase was consistent with literature. (PMID : 11553333)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF4EBP1 antibody [Y330] (AB32130)
ab32130, staining human prostate carcinoma by immunohistochemistry, Paraffin embedded tissue
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-eIF4EBP1 antibody [Y330] (AB32130)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32130 observed at 20 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32130 was shown to specifically react with eIF4EBP1 when eIF4EBP1 knockout samples were used. Wild-type and eIF4EBP1 knockout samples were subjected to SDS-PAGE. ab32130 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-eIF4EBP1 antibody [Y330] (ab32130) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
eIF4EBP1 knockout HAP1 cell lysate at 20 µg
Lane 3:
Hek293 cell lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
Predicted band size: 13 kDa
false
- WB
Unknown
Western blot - Anti-eIF4EBP1 antibody [Y330] (AB32130)
All lanes:
Western blot - Anti-eIF4EBP1 antibody [Y330] (ab32130) at 1/1000 dilution
All lanes:
K562 cell lysate
Predicted band size: 13 kDa
Observed band size: 18 kDa
false
- WB
Lab
Western blot - Anti-eIF4EBP1 antibody [Y330] (AB32130)
Lanes 1-2 : Merged signal (red and green). Green - ab32130 observed at 13 kDa. Red - loading control ab8245 observed at 37 kDa.
ab32130 Anti-eIF4EBP1 antibody [Y330] was shown to specifically react with eIF4EBP1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264784 (knockout cell lysate ab257146) was used. Wild-type and eIF4EBP1 knockout samples were subjected to SDS-PAGE. ab32130 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 Dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-eIF4EBP1 antibody [Y330] (ab32130) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
EIF4EBP1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human EIF4EBP1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-eif4ebp1-knockout-hela-cell-line-ab264784'>ab264784</a>)
Predicted band size: 13 kDa,36 kDa
Observed band size: 13 kDa
false
Related conjugates and formulations (1)
-
Anti-eIF4EBP1 antibody [Y330] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4EBP1 plays an important role in regulating cell growth and proliferation by modulating protein synthesis. It is a part of the eIF4F complex which is responsible for the initiation of mRNA translation. When hypophosphorylated eIF4EBP1 binds tightly to eIF4E and prevents the assembly of the active eIF4F complex leading to reduced translation initiation of mRNAs involved in growth and survival. This regulation is important in conditions where cells need to adapt to metabolic stress or external signals.
Pathways
The mammalian target of rapamycin (mTOR) pathway regulates eIF4EBP1 through phosphorylation. In response to growth signals mTOR phosphorylates eIF4EBP1 causing the release of eIF4E and allowing mRNA translation to proceed. This interaction links eIF4EBP1 to the PI3K/AKT/mTOR signaling pathway which influences cell cycle progression and survival. Related proteins in this pathway include ribosomal protein S6 kinase (S6K1) which is also phosphorylated by mTOR to promote protein synthesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 11:24005 PubMed34907287
2021
Applications
Unspecified application
Species
Unspecified reactive species
Animal cells and systems 25:283-295 PubMed34745435
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 17:2970-2983 PubMed34345220
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical and biophysical research communication 527:489-495 PubMed32336547
2020
Applications
Unspecified application
Species
Unspecified reactive species
Pathology international 70:323-329 PubMed32067331
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 19:584-589 PubMed29708815
2018
Applications
Unspecified application
Species
Unspecified reactive species
Mycology 7:64-73 PubMed30123617
2016
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 6:e2005 PubMed26633711
2015
Applications
Unspecified application
Species
Human
PloS one 9:e92099 PubMed24637915
2014
Applications
WB
Species
Human
Journal of the American Society of Nephrology : JA 23:1351-63 PubMed22773827
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com